Equities

StimCell Enegetics Inc

CMXCD:PKC

StimCell Enegetics Inc

Actions
  • Price (USD)0.484
  • Today's Change-0.001 / -0.21%
  • Shares traded108.00
  • 1 Year change-34.15%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 16:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

StimCell Enegetics Inc., formerly Cell MedX Corp., is a development stage electroceutical medical device company. The Company’s products include eBalance, and Bio Feedback. The eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms. The biofeedback mechanism is where eBalance offering users and health professionals alike a real-time snapshot of cellular vitality. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling. Microcurrent is a clinically tested therapy treatment used to treat a range of conditions. There is compelling research in diabetes care, wound therapy, migraine treatment, chronic obstructive pulmonary disease (COPD), and anti-ageing.

  • Revenue in USD (TTM)0.00
  • Net income in USD-132.46k
  • Incorporated2010
  • Employees0.00
  • Location
    StimCell Enegetics Inc123 W. Nye Ln, Suite 446CARSON CITY 89706United StatesUSA
  • Phone+1 (310) 508-9398
  • Fax+1 (775) 884-9383
  • Websitehttps://stimcell.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NKGen Biotech Inc0.00-88.25m8.90m63.00---------3.74-3.740.00-2.710.00----0.00-480.25-----------------0.4822-----100.00---210.06------
Mustang Bio Inc0.00-23.42m9.05m80.00---------1.71-1.710.00-0.22980.00----0.00-168.70-70.02---79.98--------------------33.44---60.75--
Galecto Inc0.00-21.17m9.07m13.00--0.4127-----19.33-19.330.0016.700.00----0.00-57.67-48.46-72.47-52.36------------0.00------37.77------
Soligenix Inc494.62k-7.04m9.11m13.00--1.62--18.42-9.58-9.580.61522.250.0418--8.7038,047.69-59.45-75.40-121.64-154.328.7522.83-1,423.81-620.02----0.4421---11.54-30.6755.50------
Jaguar Health Inc10.19m-35.67m9.13m49.00--0.4573--0.8961-41.34-41.346.622.480.17930.2317.56207,857.10-63.73-95.29-110.34-163.5479.7967.28-355.51-522.281.60-3.450.6333---18.3617.1912.97------
Cardio Diagnostics Holdings Inc39.14k-8.77m9.42m7.00--2.33--240.65-0.4899-0.48990.00210.13190.0073--9.135,591.43-163.16---268.73-------22,414.13-----9.320.0295--1,696.84---79.72------
StimCell Enegetics Inc0.00-132.46k9.59m0.00---------0.0011-0.00110.00-0.00310.00-------312.66-703.78------84.03---2,996.54---9.58-----100.00--71.22------
Conduit Pharmaceuticals Inc0.00-5.17m9.59m7.00---------0.0667-0.06670.00-0.07380.00----0.00-312.39-----------------21.32--------89.05------
Vincerx Pharma Inc0.00-28.90m9.61m42.00--0.6223-----1.31-1.310.000.52060.00----0.00-101.76---136.61--------------0.00------36.24------
Syros Pharmaceuticals Inc386.00k-97.82m9.63m68.00------24.96-3.03-3.030.0105-0.41450.0033----5,676.47-84.04-54.44-111.15-64.32-----25,340.67-772.82---179.011.37---33.2337.12-73.87---27.78--
Vaccinex Inc356.00k-17.76m9.64m37.00------27.09-24.59-24.590.3183-1.810.1306--0.67429,621.62-651.39-262.29---------4,987.92-4,257.17---52.60----107.27-4.67-2.20---22.20--
Dominari Holdings Inc9.51m-22.02m9.79m26.00--0.23--1.03-3.85-3.851.676.780.1629--2.60365,730.80-37.71-26.82-39.96-27.45-----231.55-3,353.52---5.050.00----135.7512.72--63.99--
Evaxion Biotech A/S - ADR3.30m-11.46m9.81m49.00------2.98-16.80-16.800.8311--------67,244.90---100.11---131.65-----347.86-131,560.30------------4.51--65.53--
Senti Biosciences Inc338.00k-78.62m10.30m48.00--0.233--30.48-17.52-12.650.07499.660.0029--1.127,041.67-68.20---74.50-------23,259.47------0.0023---40.25---67.94------
Kiora Pharmaceuticals Inc16.02m2.67m10.32m12.00--0.30873.820.6444-7.76-7.766.6111.140.5279--7.161,335,000.0010.54-70.5211.20-81.86----19.98-2,040.61----0.00------3.97------
Data as of Nov 13 2024. Currency figures normalised to StimCell Enegetics Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.